These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25102038)

  • 1. Palliative treatment for advanced biliary adenocarcinomas with combination dimethyl sulfoxide-sodium bicarbonate infusion and S-adenosyl-L-methionine.
    Hoang BX; Tran HQ; Vu UV; Pham QT; Shaw DG
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):206-11. PubMed ID: 25102038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl sulfoxide-sodium bicarbonate infusion for palliative care and pain relief in patients with metastatic prostate cancer.
    Hoang BX; Le BT; Tran HD; Hoang C; Tran HQ; Tran DM; Pham CQ; Pham TD; Ha TV; Bui NT; Shaw DG
    J Pain Palliat Care Pharmacother; 2011; 25(4):350-5. PubMed ID: 21936635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl sulfoxide and sodium bicarbonate in the treatment of refractory cancer pain.
    Hoang BX; Tran DM; Tran HQ; Nguyen PT; Pham TD; Dang HV; Ha TV; Tran HD; Hoang C; Luong KN; Shaw DG
    J Pain Palliat Care Pharmacother; 2011; 25(1):19-24. PubMed ID: 21426213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
    Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
    Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
    Daines WP; Rajagopalan V; Grossbard ML; Kozuch P
    Oncology (Williston Park); 2004 Jul; 18(8):1049-59; discussion 1060, 1065-6, 1068. PubMed ID: 15328897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
    Rajagopalan V; Daines WP; Grossbard ML; Kozuch P
    Oncology (Williston Park); 2004 Jun; 18(7):889-96. PubMed ID: 15255172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
    Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
    Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.
    Park SH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
    Cancer; 2006 Jan; 106(2):361-5. PubMed ID: 16342166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-1 monotherapy in patients with advanced biliary tract cancer.
    Sasaki T; Isayama H; Yashima Y; Yagioka H; Kogure H; Arizumi T; Togawa O; Matsubara S; Ito Y; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tada M; Kawabe T; Omata M
    Oncology; 2009; 77(1):71-4. PubMed ID: 19556812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
    Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
    Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
    Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer; 2005 Jun; 103(11):2338-43. PubMed ID: 15825161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
    Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
    Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.